Third Rock Ventures III, L.P. Insider Trading $MYOK MyoKardia, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Third Rock Ventures III, L.P..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Third Rock Ventures III, L.P.. Third Rock Ventures III, L.P. is 10% Owner in Nurix Therapeutics, Inc. ($NRIX) and 10% Owner in MyoKardia Inc ($MYOK) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Voyager Therapeutics, Inc. ($VYGR) and 10% Owner in Editas Medicine, Inc. ($EDIT) and 10% Owner in Fulcrum Therapeutics, Inc. ($FULC) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Neon Therapeutics, Inc. ($NTGN) and 10% Owner in PLIANT THERAPEUTICS, INC. ($PLRX) and 10% Owner in Relay Therapeutics, Inc. ($RLAY).

Third Rock Ventures III, L.P. in MyoKardia, Inc.

Trading Symbol: MYOK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures III, L.P.: 10% Owner
Holdings: 680,272 shares
Current Value: $8,163,264
Latest Transaction: Jan 05 2018
$MYOK Market Capitalization: $375.56M
$MYOK Previous Close: $12.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Third Rock Ventures III, L.P. in MyoKardia, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, EDIT, FULC, GBT, MYOK, NTGN, NRIX, PLRX, RLAY, RVMD, VYGR

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 05 2018	MYOK	MyoKardia Inc	Third Rock Ventures III, L.P.	10% Owner	Sell	S	42.00	816,326	34,285,774	680,272	1.5 M to 680.3 K (-54.55 %)

Page: 1